4[4]Takahashi A.Caspase:executioner and undertaker of apoptosis.Int J Hematol,1999,70:226-232.
5[5]Van de Craen M,Van den Brande I,Declercq W,et al.Cleavage of caspase family members by granzyme B:a comparative study in vitro[J].Eur J Immunol,1997,27:1296-1299.
6[6]Zhou Q,Salvesen GS.Activation of Pro-Caspase-7 by serine proteases includes a non-canonical specificity[J].Biochem J,1997,324:361-364.
7[7]anielPT.Dissecting the pathways to death[J].Leukemia,2000,14:2035-2044.
8[8]Lin QS.Mitochondria and apoptosis[J].Acta Biochimica et Biophysica,1999,31(2):116-121.
9[9]Crompton M.The mitochondrial permeability transition pore and its role in cell death[J].Biochem J,1999,341(Pt2):233-249.
10[10]Cain K,Bratton SB,Langlais C,et al.Apaf-1 oligomerizes into biologically active―700kD and inactive-1.4 kDa apoptosome complexes[J].J Biol Chem,2000,275(9):6067-6070.
二级参考文献49
1[1]ChangHY et al. Micro Mol Biol Rev, 2000; 64:821
2[2]Lin XY et al. J Biol Chem, 2000; 275:39920
3[3]Cohen GM. Biochm J 1997; 326:1
4[4]Hu S et al. J Biol Chem, 1998; 273:29648
5[5]Takahashi A. Int J Hematol, 1999; 70:226
6[6]Earnshaw WC et al. Annu Rev Biochem,1999;68:383
5Asakura T, Ikim T Y. Prognostic value of Ki-67 for rec- urence and progression of superficial bladder cancer [J]. Virology 1997, 158(2): 385-388.
6Green D R. Apoptotic pathways: the roads to ruin [J]. Cell, 1998, 94(6): 695-698.
7Tong X, Lin S, Fujii M, et al. Moleculer mechanisms of echincystic acid-induced apoptosis in HepG2 cells [J]. Biochem Biophys Res Commun, 2004, 321(3): 539-546.
8Dougherty T J, Gomer C J, Henderson B W, et al. Photodynamic therapy [J]. J Natl Catlcer Inst, 1998, 90(12): 889-905.
9Lu S L, Zhang W C, Akiyama Y, et al. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers [J]. Cancer Res, 1996, 56(20): 4595-4598.
10Tuxhom J A, McAlhany S J, Yang F, et al. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograh model [J]. Cancer Res, 2002, 62(21): 6021-6025.
